Skip to main content

The Public Health and Clinical Implications of the National Increase in Congestive Heart Failure

  • Chapter
Book cover Congestive Heart Failure

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 75))

  • 28 Accesses

Abstract

The last two decades have witnessed a substantial decline in mortality due to myocardial infarction and stroke. However, during a similar period, data obtained from the National Center for Health Statistics indicate that the number of deaths due to congestive heart failure (CHF) has increased more than four-fold; for example, the number of deaths in which CHF was considered to be the underlying cause increased from about 6000 in 1955 to over 30,000 by 1982. There was a parallel increase in the number of deaths in which CHF was considered to be a contributing cause, from 51,000 in 1955 to about 246,000 in 1982. Although a substantial part of this increase can be explained by the aging of the population, the age-adjusted death rates also show a two-fold increase. For example, the age adjusted death rates, where CHF was the underlying cause, increased from 3.5/100,000 in 1968 to about 7.5/100,000 by 1984. The incidence of CHF and deaths due to CHF increased exponentially with age in both sexes and all races. However for any specific age group, CHF mortality is about 1.6 times commoner in men and about two to three times commoner in blacks compared to whites.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Applefeld MM: Chronic Congestive Heart Failure: Where have we been? Where are we heading? Am J Med 80 Suppl 2B: 73–77, 1986.

    Article  PubMed  CAS  Google Scholar 

  2. McKee PA, Castelli WP, McNamara PM, et al: The natural history of congestive heart failure: The Framingham Study. N Engl J Med 285: 1441–1446, 1971.

    Article  PubMed  CAS  Google Scholar 

  3. Fisher LD, Alderman EL, Mock MB, Chaitman BR, Ringqvist I, Ryan TJ, Levine F, Kaiser GC, Schloss M, Killip T, Oberman A, Litwin P: Statistical Considerations in Evaluating Treatment of Advanced Congestive heart failure. In Congestive Heart Failure. Ed Braunwald E, Mock MB and Watson JT: p 357–366. Grune and Stratton Inc., 1982

    Google Scholar 

  4. Wilson JR, Schwartz JS, St. John-Sutton M, et al: Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity. J Amer Coll Cardiol 2: 403–410, 1983.

    Article  CAS  Google Scholar 

  5. Cohn JN, Archibald DG, Ziesche S, et al: Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 314: 1547–1552, 1986.

    Article  PubMed  CAS  Google Scholar 

  6. Franciosa JA, Wilen M, Ziesche S and Cohn JN: Survival in Men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51: 831–835, 1983.

    Article  PubMed  CAS  Google Scholar 

  7. Schwarz F, Mall G, Zebe H, et al: Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation 70: 923–928, 1984.

    Article  PubMed  CAS  Google Scholar 

  8. Fuster V, Gersh BJ, Giuliani ER, et al: The Natural History of Idiopathic Dilated Cardiomyopathy. Am J Cardiol 47: 525–531, 1981.

    Article  PubMed  CAS  Google Scholar 

  9. Massie B, Ports T, Chatterjee K, et al: Long-term vasodilator therapy for heart failure: Clinical Response and its relationship to hemodynamic measurements. Circulation 63: 269–278, 1981.

    Article  PubMed  CAS  Google Scholar 

  10. Unverferth DV, Magorien RD, Moeschberg ML, et al: Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147–152, 1984.

    Article  PubMed  CAS  Google Scholar 

  11. Studies of Left Ventricular Dysfunction — Protocol, 1986.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Yusuf, S., Thom, T., Probstfield, J. (1987). The Public Health and Clinical Implications of the National Increase in Congestive Heart Failure. In: Morganroth, J., Moore, E.N. (eds) Congestive Heart Failure. Developments in Cardiovascular Medicine, vol 75. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2077-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2077-7_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9232-6

  • Online ISBN: 978-1-4613-2077-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics